Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Enregistré dans:
Auteurs principaux: | Jianbo Dong, Betty Huang, Bo Wang, Allison Titong, Sachith Gallolu Kankanamalage, Zhejun Jia, Meredith Wright, Pannaga Parthasarathy, Yue Liu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c7504889cf7242c099524d8e63f1fa4c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
par: Dapeng Sun, et autres
Publié: (2021) -
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
par: Xun Chen, et autres
Publié: (2021) -
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
par: Leo Hanke, et autres
Publié: (2020) -
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
par: Guillermo Valenzuela Nieto, et autres
Publié: (2021) -
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
par: Tânia F. Custódio, et autres
Publié: (2020)